Literature DB >> 20095917

Diuretics in clinical practice. Part I: mechanisms of action, pharmacological effects and clinical indications of diuretic compounds.

Pantelis A Sarafidis1, Panagiotis I Georgianos, Anastasios N Lasaridis.   

Abstract

IMPORTANCE OF THE FIELD: Diuretics are among the most important drugs of our therapeutic armamentarium and have been broadly used for > 50 years, providing important help towards the treatment of several diseases. Although all diuretics act primarily by impairing sodium reabsorption in the renal tubules, they differ in their mechanism and site of action and, therefore, in their specific pharmacological properties and clinical indications. Loop diuretics are mainly used for oedematous disorders (i.e., cardiac failure, nephrotic syndrome) and for blood pressure and volume control in renal disease; thiazides and related agents are among the most prescribed drugs for hypertension treatment; aldosterone-blockers are traditionally used for primary or secondary aldosteronism; and other diuretic classes have more specific indications. AREAS COVERED IN THIS REVIEW: This article discusses the mechanisms of action, pharmacological effects and clinical indications of the various diuretic classes used in everyday clinical practice, with emphasis on recent knowledge suggesting beneficial effects of certain diuretics on clinical conditions distinct from the traditional indications of these drugs (i.e., heart protection for aldosterone blockers). WHAT THE READER WILL GAIN: Reader will gain insights into the effective use of diuretic agents for various medical conditions, representing their established or emerging therapeutic indications. TAKE HOME MESSAGE: Knowledge of the pharmacologic properties and mechanisms of action of diuretic agents is a prerequisite for the successful choice and effective clinical use of these compounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20095917     DOI: 10.1517/14740330903499240

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  7 in total

1.  Gallic acid, a phenolic compound isolated from Mimosa bimucronata (DC.) Kuntze leaves, induces diuresis and saluresis in rats.

Authors:  Fabile Schlickmann; Thaise Boeing; Luisa Nathália Bolda Mariano; Rita de Cássia Melo Vilhena de Andrade Fonseca da Silva; Luisa Mota da Silva; Sérgio Faloni de Andrade; Priscila de Souza; Valdir Cechinel-Filho
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-04-16       Impact factor: 3.000

Review 2.  Diuretics and the kidney.

Authors:  R Bell; R Mandalia
Journal:  BJA Educ       Date:  2022-04-20

Review 3.  Approach and management of dysnatremias in cirrhosis.

Authors:  Mauro Bernardi; Giacomo Zaccherini
Journal:  Hepatol Int       Date:  2018-09-10       Impact factor: 6.047

4.  Treating Hypertension in Diabetic Patients With Advanced Chronic Kidney Disease: What Should We Have in Mind?

Authors:  Panagiotis I Georgianos; Elias V Balaskas; Pantelis E Zebekakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-05-11       Impact factor: 3.738

5.  Evaluation of the Diuretic Activity of the Aqueous and 80% Methanol Extracts of Ficus sur Forssk (Moraceae) Leaves in Saline-loaded Rats.

Authors:  Mesfin Ayele; Eyasu Makonnen; Akeberegn Gorems Ayele; Yosef Tolcha
Journal:  J Exp Pharmacol       Date:  2020-12-16

Review 6.  Casein kinase 1α: biological mechanisms and theranostic potential.

Authors:  Shaojie Jiang; Miaofeng Zhang; Jihong Sun; Xiaoming Yang
Journal:  Cell Commun Signal       Date:  2018-05-24       Impact factor: 5.712

Review 7.  SGLT-2 inhibitors and nephroprotection: current evidence and future perspectives.

Authors:  Alexia Piperidou; Charalampos Loutradis; Pantelis Sarafidis
Journal:  J Hum Hypertens       Date:  2020-08-10       Impact factor: 3.012

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.